1. Introduction {#sec1-molecules-23-02286}
===============

*Hernanadia nymphaeifolia* (Presl) Kubitzki (Hernandiaceae) is an evergreen tree that is distributed in the tropical island shores of the Indian and western Pacific Oceans \[[@B1-molecules-23-02286]\]. Its seed is used as a cathartic \[[@B2-molecules-23-02286]\]. Various aporphines \[[@B3-molecules-23-02286],[@B4-molecules-23-02286],[@B5-molecules-23-02286],[@B6-molecules-23-02286],[@B7-molecules-23-02286]\], isoquinolones \[[@B4-molecules-23-02286],[@B5-molecules-23-02286]\], lignans \[[@B4-molecules-23-02286],[@B7-molecules-23-02286],[@B8-molecules-23-02286]\], benzylisoquinoline \[[@B5-molecules-23-02286]\], steroids \[[@B7-molecules-23-02286]\], and their derivatives were isolated from this species in past studies. Many of these isolates display cytotoxic \[[@B4-molecules-23-02286],[@B5-molecules-23-02286],[@B8-molecules-23-02286]\], vasorelaxing \[[@B6-molecules-23-02286]\], antioxidant \[[@B6-molecules-23-02286]\], and antiplatelet aggregation \[[@B7-molecules-23-02286]\] activities.

The extensive or inappropriate activation of neutrophils leads to many inflammatory disorders such as chronic obstructive pulmonary disease (COPD), ischemia-reperfusion injury, asthma, rheumatoid arthritis, and metabolic diseases \[[@B9-molecules-23-02286],[@B10-molecules-23-02286]\]. In response to various stimuli, activated neutrophils secrete a series of cytotoxins, such as granule proteases, bioactive lipids, and superoxide anion (O~2~^•--^), a precursor of other reactive oxygen species (ROS) \[[@B10-molecules-23-02286],[@B11-molecules-23-02286],[@B12-molecules-23-02286]\]. The inhibition of the abnormal activation of neutrophils by medicines has been recommended as a way to improve inflammatory diseases. In our researches on the anti-inflammatory constituents of Formosan plants, numerous species have been screened for anti-inflammatory activity, and *H. nymphaeifolia* has been found to be an active species. A new aporphine, 3-hydroxyhernandonine (**1**), a new lignin, 4′-*O*-demethyl-7-*O*-methyldehydropodophyllotoxin (**2**), and thirteen known compounds (**3**--**15**) have been isolated and determined from the root wood of *Hernanadia nymphaeifolia,* and their structures are described in [Figure 1](#molecules-23-02286-f001){ref-type="fig"}.

This article describes the structural elucidation of new compounds **1** and **2** and the inhibitory effects of all isolates on elastase release and superoxide generation by human neutrophils.

2. Results and Discussion {#sec2-molecules-23-02286}
=========================

2.1. Isolation and Structural Elucidation {#sec2dot1-molecules-23-02286}
-----------------------------------------

Chromatographic purification of the CH~2~Cl~2~-soluble fraction of a MeOH extract of root wood of *H. nymphaeifolia* through a silica gel column, medium pressure liquid chromatography (MPLC), and preparative thin-layer chromatography (TLC) yielded two new (**1** and **2**) and thirteen known compounds (**3**--**15**) ([Figure 1](#molecules-23-02286-f001){ref-type="fig"}).

The aporphine, 3-hydroxyhernandonine (**1**), was obtained as yellow needles. The electrospray ionization mass spectrometry (ESI-MS) ([Figure S1](#app1-molecules-23-02286){ref-type="app"}) afford the quasi-molecular ion \[M + Na\]^+^ at *m*/*z* 358, implying a molecular formula of C~18~H~9~NO~6~Na, which was confirmed by the high-resolution (HR)-ESI-MS (*m*/*z* 358.0325 \[M + Na\]^+^, calcd 358.0328) (− 0.84 ppm) ([Figure S2](#app1-molecules-23-02286){ref-type="app"}) and by the ^13^C-, ^1^H-, and distortionless enhancement by polarization transfer (DEPT) NMR data. IR absorptions for OH (3439 cm^−1^) and conjugated carbonyl (1646 cm^−1^) functions were observed. The ^1^H-NMR spectrum ([Figure S3](#app1-molecules-23-02286){ref-type="app"}) of **1** showed the presence of a hydroxy group at δ~H~ 6.52 (1H, s, D~2~O exchangeable, OH-3), two methylenedioxy groups at δ~H~ 6.20 (2H, s, OCH~2~O-10,11) and 6.28 (2H, s, OCH~2~O-1,2), and two pairs of AB-doublets at δ~H~ 7.08 (1H, d, *J* = 8.5 Hz, H-9), 8.10 (1H, d, *J* = 5.0 Hz, H-4), 8.28 (1H, d, *J* = 8.5 Hz, H-8), and 8.88 (1H, d, *J* = 5.0 Hz, H-5). The ^1^H- and ^13^C-NMR ([Figure S4](#app1-molecules-23-02286){ref-type="app"}) data of **1** were similar to those of hernandonine \[[@B13-molecules-23-02286],[@B14-molecules-23-02286]\], except that the 3-hydroxy group \[δ~H~ 6.52 (1H, s, D~2~O exchangeable)\] of **1** replaced H-3 of hernandonine \[[@B13-molecules-23-02286],[@B14-molecules-23-02286]\]. This was supported by HMBC correlations between OH-3 (δ~H~ 6.52) and C-2 (δ~C~ 139.2), as well as between C-3 (δ~C~ 148.4), and C-3a (δ~C~ 123.9). The full assignment of ^1^H- and ^13^C-NMR resonances was supported by DEPT, ^1^H--^1^H COSY ([Figure S5](#app1-molecules-23-02286){ref-type="app"}), NOESY ([Figure 2](#molecules-23-02286-f002){ref-type="fig"} and [Figure S6](#app1-molecules-23-02286){ref-type="app"}), HMBC ([Figure 2](#molecules-23-02286-f002){ref-type="fig"} and [Figure S7](#app1-molecules-23-02286){ref-type="app"}), and HSQC ([Figure S8](#app1-molecules-23-02286){ref-type="app"}) spectral analyses. Based on the above data, the structure of **1** was revealed as 3-hydroxyhernandonine.

4′-*O*-Demethyl-7-*O*-methyldehydropodophyllotoxin (**2**) was isolated as colorless needles. The ESI-MS ([Figure S9](#app1-molecules-23-02286){ref-type="app"}) display the sodium adduct ion \[M + Na\]^+^ at *m*/*z* 433, hinting a molecular formula of C~22~H~18~O~8~, which was supported by the HR-ESI-MS (*m*/*z* 433.0898 \[M + Na\]^+^, calcd 433.0899) (-- 0.23 ppm) ([Figure S10](#app1-molecules-23-02286){ref-type="app"}). The IR spectrum showed the presence of OH (3452 cm^−1^) and γ-lactone carbonyl (1764 cm^−1^) groups. The ^1^H-NMR spectrum ([Figure S11](#app1-molecules-23-02286){ref-type="app"}) of **2** showed the presence of three methoxy groups at δ~H~ 3.88 (6H, s, OMe-3′ and OMe-5′) and 4.09 (3H, s, OMe-7), a hydroxyl group at δ~H~ 5.65 (1H, br s, D~2~O exchangeable, OH-4′), a methylenedioxy group at δ~H~ 6.09 (2H, s, OCH~2~O), a γ-lactone methylene proton at 5.52 (2H, s, H-9), and four aromatic protons at δ~H~ 6.57 (2H, s, H-2′ and H-6′), 7.07 (1H, s, H-5), and 7.57 (1H, s, H-2). The ^1^H- and ^13^C-NMR ([Figure S12](#app1-molecules-23-02286){ref-type="app"}) data of **2** were similar to those of 4′-*O*-demethyldehydropodophyllotoxin \[[@B15-molecules-23-02286]\], except that the 7-methoxy groups \[δ~H~ 4.09 (3H, s); δ~C~ 59.9 (OMe-7)\] of **2** replaced the 7-OH group of 4′-*O*-demethyldehydropodophyllotoxin \[[@B15-molecules-23-02286]\]. This was supported by NOESY correlations between OMe-7 (δ~H~ 4.09) and H-2 (δ~H~ 7.57) and by HMBC correlations between OMe-7 (δ~H~ 4.09) and C-7 (δ~C~ 148.5). According to the above evidence, the structure of **2** was elucidated as 4′-*O*-demethyl-7-*O*-methyldehydropodophyllotoxin. This was further affirmed by the ^1^H--^1^H-COSY ([Figure S13](#app1-molecules-23-02286){ref-type="app"}), NOESY ([Figure 3](#molecules-23-02286-f003){ref-type="fig"} and [Figure S14](#app1-molecules-23-02286){ref-type="app"}), DEPT, HMBC ([Figure 3](#molecules-23-02286-f003){ref-type="fig"} and [Figure S15](#app1-molecules-23-02286){ref-type="app"}), and HSQC ([Figure S16](#app1-molecules-23-02286){ref-type="app"}) experiments.

2.2. Structure Identification of the Known Isolates {#sec2dot2-molecules-23-02286}
---------------------------------------------------

The known isolated compounds were readily confirmed by a comparison of spectroscopic and physical data (IR, UV, ^1^H-NMR, MS, and \[α\]~D~) with the literature values or corresponding authentic samples, and this included five aporphines, 2-*O*-methyl-7-oxolaetine (**3**) \[[@B16-molecules-23-02286]\], hernandonine (**4**) \[[@B13-molecules-23-02286],[@B14-molecules-23-02286]\], oxohernangerine (**5**) \[[@B17-molecules-23-02286]\], oxohernagine (**6**) \[[@B17-molecules-23-02286]\], and 7-oxonorisocorydine (**7**) \[[@B18-molecules-23-02286]\], three lignans, (--)-deoxypodophyllotoxin (**8**) \[[@B19-molecules-23-02286],[@B20-molecules-23-02286]\], dehydropodophyllotoxin (**9**) \[[@B20-molecules-23-02286],[@B21-molecules-23-02286]\], (--)-yatein (**10**) \[[@B20-molecules-23-02286]\], an amide, *N*-*trans*-feruloylmethoxytyramine (**11**) \[[@B22-molecules-23-02286]\], four steroids, a mixture of β-sitostenone (**12**) \[[@B23-molecules-23-02286]\] and stigmasta-4,22-dien-3-one (**13**) \[[@B23-molecules-23-02286]\], and mixture of 6 β-hydroxystigmast-4-en-3-one (**14**) \[[@B24-molecules-23-02286],[@B25-molecules-23-02286]\] and 6 β-hydroxystigmasta-4,22-dien-3-one (**15**) \[[@B24-molecules-23-02286],[@B25-molecules-23-02286]\].

2.3. Biological Studies {#sec2dot3-molecules-23-02286}
-----------------------

Granule proteases (e.g., cathepsin G, elastase, and proteinase-3) and reactive oxygen species (ROS) (e.g., hydrogen peroxide and superoxide anion (O~2~^•−^)) generated by human neutrophils are involved in the pathogenesis of various NMR data \[[@B10-molecules-23-02286],[@B11-molecules-23-02286],[@B12-molecules-23-02286],[@B26-molecules-23-02286]\]. The activities during neutrophil proinflammatory responses to isolates from the root wood of *H. nymphaeifolia* were assessed by inhibiting fMet-Leu-Phe/cytochalasin B (fMLP/CB)-induced O~2~^•--^ production and elastase release by human neutrophils. The inhibitory activity data on neutrophil proinflammatory responses are shown in [Table 1](#molecules-23-02286-t001){ref-type="table"}. Diphenyleneiodonium and phenylmethylsulfonyl fluoride were employed as positive controls for O~2~^•--^ generation and elastase release, respectively \[[@B26-molecules-23-02286]\]. From the results of our biological assays, the following conclusions can be summarized: (a) 3-hydroxyhernandonine (**1**), 4′-*O*-demethyl-7-*O*-methyldehydropodophyllotoxin (**2**), hernandonine (**4**), oxohernangerine (**5**), and oxohernagine (**6**) exhibited potent inhibition (IC~50~ ≤ 5.72 μg/mL) of superoxide anion (O~2~^•--^) generation by human neutrophils in response to fMLP/CB; (b) 3-hydroxyhernandonine (**1**), 4′-*O*-demethyl-7-*O*-methyldehydropodophyllotoxin (**2**), oxohernangerine (**5**), and oxohernagine (**6**) exhibited potent inhibition (IC~50~ ≤ 5.40 μg/mL) of fMLP-induced elastase release; (c) the aporphine alkaloid, 3-hydroxyhernandonine (**1**) (with a 3-hydroxy group), exhibited more effective inhibition than its analogue, hernandonine (**4**) (without any substitutant at C-3), against fMLP-induced O~2~^•--^ generation and elastase release; (d) oxohernagine (**6**) (with 10-hydroxy and 11-methoxy groups) exhibited more effective inhibition of fMLP-induced O~2~^•--^ generation and elastase release than its analogue, 7-oxonorisocorydine (**7**) (with 11-hydroxy and 10-methoxy groups; (e) the lignan compound, 4′-*O*-demethyl-7-*O*-methyldehydroodophyllotoxin (**2**) (with 7-methoxy and 4′-hydroxy groups) exhibited more effective inhibition of fMLP-induced O~2~^•--^ generation and elastase release than its analogue, dehydropodophyllotoxin (**9**) (with 7-hydroxy and 4′-methoxy groups); (f) oxohernangerine (**5**) was the most effective among these compounds, with an IC~50~ value of 2.65 ± 0.97 μg/mL, against fMLP-induced superoxide anion generation; (g) 3-hydroxyhernandonine (**1**) was the most effective among the isolates, with an IC~50~ value of 3.93 ± 0.48 μg/mL against fMLP-induced elastase release.

3. Experimental Section {#sec3-molecules-23-02286}
=======================

3.1. General Procedures {#sec3dot1-molecules-23-02286}
-----------------------

Melting points were determined on a Yanaco micromelting point apparatus and were uncorrected. Ultraviolet (UV) spectra were measured on a Jasco UV-240 spectrophotometer. Optical rotations were acquired using a Jasco DIP-370 polarimeter (Japan Spectroscopic Corporation, Tokyo, Japan) in CHCl~3~. Infrared (IR) spectra (KBr or neat) were recorded on a Perkin Elmer 2000 FT-IR spectrometer (Perkin Elmer Corporation, Norwalk, CT, USA). Nuclear magnetic resonance (NMR) spectra, including correlation spectroscopy (COSY), nuclear overhauser effect spectrometry (NOESY), heteronuclear multiple-bond correlation (HMBC) experiments, and heteronuclear single-quantum coherence (HSQC), were obtained using a Varian Inova 500 spectrometer (Varian Inc., Palo Alto, CA, USA) operating at 500 MHz (^1^H) and 125 MHz (^13^C), respectively, with chemical shifts given in ppm (δ) and applying tetramethylsilane (TMS) as an internal standard. Electrospray ionization (ESI) and high-resolution electrospray ionization (HRESI)-mass spectra were recorded on a VG Platform Electrospray ESI/MS mass spectrometer (Fison, Villeurbanne, France) or a Bruker APEX II (Bruker, Bremen, Germany). Silica gel (70--230, 230--400 mesh, Merck) was used for column chromatography (CC). Silica gel 60 F-254 (Merck, Darmstadt, Germany) was employed for thin-layer chromatography (TLC) and preparative thin-layer chromatography (PTLC).

3.2. Plant Material {#sec3dot2-molecules-23-02286}
-------------------

The root wood of *Hernanadia nymphaeifolia* (Presl) Kubitzki (Hernandiaceae) was collected from Mudan Township, Pingtung County, Taiwan, in August 2008 and identified by Prof. I.-S. Chen. A voucher specimen (Chen 5521) was deposited in the Herbarium of School of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.

3.3. Extraction and Isolation {#sec3dot3-molecules-23-02286}
-----------------------------

The dried root wood (5.1 kg) of *H. nymphaeifolia* was sliced and extracted three times with MeOH (40 L each) for three days. The extract was concentrated under reduced pressure at 35 °C, and the residue (386 g) was partitioned between CH~2~Cl~2~ and H~2~O (1:1) to provide the CH~2~Cl~2~-soluble fraction (fraction A; 87 g). Fraction A (87 g) was purified by CC (3.9 kg of SiO~2~, 70--230 mesh; CH~2~Cl~2~/MeOH gradient) to produce 12 fractions: A1--A12. Fraction A3 (7.5 g) was subjected to CC (340 g of SiO~2~, 230--400 mesh; CH~2~Cl~2~/acetone 30:1--0:1, 900 mL fractions) to give 11 subfractions: A3-1--A3-11. Fraction A3-4 (340 mg) was purified by MPLC (silica column, CH~2~Cl~2~/acetone 8:1--0:1) to produce eight subfractions (each 250 mL, A3-4-1--A3-4-8). Fraction A3-4-4 (46 mg) was purified by preparative TLC (silica gel, CHCl~3~/MeOH, 10:1) to obtain a mixture of β-sitostenone (**12**) and stigmasta-4,22-dien-3-one (**13**) (8.5 mg). Fraction A5 (6.9 g) was subjected to CC (365 g of SiO~2~, 230--400 mesh; CH~2~Cl~2~/MeOH 15:1--0:1, 950 mL fractions) to form ten subfractions: A5-1--A5-10. Fraction A5-3 (625 mg) was purified by CC (28 g of SiO~2~, 230--400 mesh, CHCl~3~/acetone (7:1--0:1), 250 mL fractions) to give nine subfractions: A5-3-1--A5-3-9. Fraction A5-3-5 (88 mg) was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/acetone 8:1) to yield a mixture of 6β-hydroxystigmast-4-en-3-one (**14**) and 6β-hydroxystigmasta-4,22-dien-3-one (**15**) (3.7 mg). Fraction A7 (7.3 g) was subjected to CC (330 g of SiO~2~, 230--400 mesh; CHCl~3~/MeOH 10:1--0:1, 800 mL fractions) to give nine subfractions: A7-1--A7-9. A part (142 mg) of fraction A7-2 was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/MeOH 15:1) to form (--)-deoxypodophyllotoxin (**8**) (7.2 mg). A part (133 mg) of fraction A7-3 was further purified by preparative TLC (SiO~2~; CHCl~3~/MeOH 12:1) to yield (--)-yatein (**10**) (5.1 mg). A part (136 mg) of fraction A7-4 was further purified by preparative TLC (SiO~2~; CHCl~3~/MeOH 9:1) to obtain 2-*O*-methyl-7-oxolaetine (**3**) (5.3 mg). A part (118 mg) of fraction A7-6 was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/MeOH 5:1) to produce 7-oxonorisocorydine (**7**) (6.5 mg). Fraction A7-7 (650 mg) was purified by MPLC (silica column, CH~2~Cl~2~/MeOH 9:1--0:1) to form seven subfractions (each 170 ml, A7-7-1--A7-7-7). A part (112 mg) of fraction A7-7-4 was further purified by preparative TLC (SiO~2~; CHCl~3~/acetone 5:1) to form 4′-*O*-demethyl-7-*O*-methyldehydropodophyllotoxin (**2**) (5.5 mg). A part (125 mg) of fraction A7-7-5 was purified by preparative TLC (SiO~2~; CH~2~Cl~2~/acetone 4:1) to obtain dehydropodophyllotoxin (**9**) (6.9 mg). A part (122 mg) of fraction A7-8 was purified by preparative TLC (SiO~2~; CH~2~Cl~2~/EtOAc 2:1) to yield *N*-*trans*-feruloylmethoxytyramine (**11**) (4.9 mg). Fraction A8 (7.2 g) was subjected to CC (325 g of SiO~2~, 230--400 mesh; CH~2~Cl~2~/MeOH 8:1--0:1, 850 mL fractions) to give ten subfractions: A8-1--A8-10. Fraction A8-2 (530 mg) was purified by MPLC (silica column, CHCl~3~/MeOH 7:1--0:1) to form six subfractions (each 180 ml, A8-2-1--A8-2-6). Fraction A8-2-4 (83 mg) was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/acetone 6:1) to obtain hernandonine (**4**) (8.2 mg). Fraction A8-5 (135 mg) was further purified by preparative TLC (SiO~2~; CH~2~Cl~2~/MeOH 4:1) to obtain oxohernagine (**6**) (7.1 mg). Fraction A8-6 (135 mg) was further purified by preparative TLC (SiO~2~; CHCl~3~/MeOH 3:1) to yield oxohernangerine (**5**) (6.5 mg). Fraction A9 (6.4 g) was subjected to CC (290 g of SiO~2~, 230--400 mesh; CHCl~3~/MeOH 6:1--0:1, 1 L fractions) to obtain eight subfractions: A9-1--A9-8. A part (142 mg) of fraction A9-3 was purified by preparative TLC (SiO~2~; CHCl~3~/MeOH 5:1) to obtain 3-hydroxyhernandonine (**1**) (4.5 mg). A part (105 mg) of fraction A9-5 was purified by preparative TLC (SiO~2~; CH~2~Cl~2~/MeOH 4:1) to obtain oxohernangerine (**5**) (5.9 mg).

*3-Hydroxyhernandonine* (**1**): yellow needles; m.p. 268--270 °C (MeOH); UV (MeOH): λ~max~ (log ε) = 220 (3.90), 268 (3.79), 284 (3.78), 343 (3.46), 362 (3.47) nm; IR (KBr): υ~max~ = 3315 (OH), 1652 (C=O), 1060, 969 (OCH~2~O) cm^−1^; ^1^H-NMR (CDCl~3~, 500 MHz): δ 6.20 (2H, s, OCH~2~O-10,11), 6.28 (2H, s, OCH~2~O-1,2), 6.52 (1H, s, D~2~O exchangeable, OH-3), 7.08 (1H, d, *J* = 8.5 Hz, H-9), 8.10 (1H, d, *J* = 5.0 Hz, H-4), 8.28 (1H, d, *J* = 8.5 Hz, H-8), 8.88 (1H, d, *J* = 5.0 Hz, H-5); ^13^C-NMR (CDCl~3~, 125 MHz): δ 101.3 (OCH~2~O-1,2), 101.7 (OCH~2~O-10,11), 108.6 (C-9), 114.9 (C-11b), 118.7 (C-8), 119.1 (C-4), 122.3 (C-11a), 122.9 (C-11c), 123.9 (C-3a), 127.6 (C-7a), 139.2 (C-2), 145.2 (C-5), 145.8 (C-11), 148.4 (C-3), 149.6 (C-1), 150.4 (C-10), 157.3 (C-6a), 182.5 (C-7); ESI-MS: *m*/*z* = 358 \[M + Na\]^+^; HR-ESI-MS: *m*/*z* = 358.0325 \[M + Na\]^+^ (calcd for C~18~H~9~NO~6~Na, 358.0328).

*4′-O-Demethyl-7-O-methyldehydropodophyllotoxin* (**2**): colorless needles; m.p. 273--275 °C (MeOH); UV (MeOH): λ~max~ (log ε) = 223 (4.47), 262 (4.58), 321 (3.98), 355 (3.69) nm; IR (KBr): υ~max~ = 3452 (OH), 1764 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 500 MHz): δ 3.88 (6H, s, OMe-3′ and OMe-5′), 4.09 (3H, s, OMe-7), 5.52 (2H, s, H-9), 5.65 (1H, br s, D~2~O exchangeable, OH-4′), 6.09 (2H, s, OCH~2~O), 6.57 (2H, s, H-2′, and H-6′), 7.07 (1H, s, H-5), 7.57 (1H, s, H-2); ^13^C-NMR (CDCl~3~, 125 MHz): δ 56.0 (OMe-3′), 56.0 (OMe-5′), 59.9 (OMe-7), 66.4 (C-9), 98.4 (C-2), 101.8 (OCH~2~O), 103.9 (C-5), 107.7 (C-2′), 107.7 (C-6′), 119.5 (C-8′), 125.8 (C-8), 127.8 (C-6), 130.4 (C-1), 132.2 (C-1′), 133.6 (C-4′), 137.7 (C-7′), 148.5 (C-7), 148.9 (C-4), 148.9 (C-3′), 148.9 (C-5′), 150.0 (C-3), 169.3 (C-9′); ESI-MS: *m*/*z* = 433 \[M + Na\]^+^; HR-ESI-MS: *m*/*z* = 433.0898 \[M + Na\]^+^ (calcd for C~22~H~18~O~8~Na, 433.0899).

*2-O-Methyl-7-oxolaetine* (**3**): yellow needles; m.p. \> 300 °C (MeOH); UV (MeOH): λ~max~ (log ε) = 221 (4.49), 266 (4.33), 362 (4.00), 427 (3.95) nm; IR (KBr): υ~max~ = 1652 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz): δ 3.93 (3H, s, OMe-1), 6.21 (2H, s, OCH~2~O-10,11), 7.08 (1H, d, *J* = 8.4 Hz, H-9), 7.21 (1H, s, H-3), 7.77 (1H, d, *J* = 5.2 Hz, H-4), 8.24 (1H, d, *J* = 8.4 Hz, H-8), 8.86 (1H, d, *J* = 5.2 Hz, H-5); ESI-MS: *m*/*z* = 358 \[M + Na\]^+^; HR-ESI-MS: *m*/*z* = 358.0692 \[M + Na\]^+^ (calcd for C~19~H~13~O~5~Na, 358.0691).

*Hernandonine* (**4**): yellow needles; m.p. \> 350 °C (CH~2~Cl~2~-MeOH); UV (MeOH): λ~max~ (log ε) = 222 (4.50), 265 (4.34), 295 (sh, 3.90), 312 (sh, 3.63), 364 (4.02), 428 (3.97) nm; IR (KBr): υ~max~ = 1651 (C=O), 1062, 971 (OCH~2~O) cm^−1^; ^1^H-NMR (CDCl~3~, 500 MHz): δ 6.20 (2H, s, OCH~2~O-10,11), 6.28 (2H, s, OCH~2~O-1,2), 7.08 (1H, d, *J* = 8.5 Hz, H-9), 7.21 (1H, s, H-3), 7.74 (1H, d, *J* = 5.0 Hz, H-4), 8.29 (1H, d, *J* = 8.5 Hz, H-8), 8.85 (1H, d, *J* = 5.0 Hz, H-5); ESI-MS: *m*/*z* = 342 \[M + Na\]^+^.

*Oxohernangerine* (**5**): yellow prisms; m.p. 257--258 °C (MeOH); UV (MeOH): λ~max~ (log ε) = 211 (4.55), 252 (4.46), 268 (sh, 4.42), 316 (3.87), 362 (4.04), 408 (4.02), 477 (3.55) nm; IR (KBr): υ~max~ = 3415 (OH), 1642 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz): δ 3.68 (3H, s, OMe-11), 6.32 (2H, s, OCH~2~O-1,2), 7.24 (1H, d, *J* = 8.4 Hz, H-9), 7.27 (1H, s, H-3), 7.76 (1H, d, *J* = 5.2 Hz, H-4), 8.37 (1H, d, *J* = 8.4 Hz, H-8), 8.86 (1H, d, *J* = 5.2 Hz, H-5); ESI-MS: *m*/*z* = 344 \[M + Na\]^+^.

*Oxohernagine* (**6**): yellow prisms; m.p. 253--255 °C (MeOH); UV (MeOH): λ~max~ (log ε) = 213 (4.51), 274 (4.41), 361 (3.95), 403 (3.92) nm; IR (KBr): υ~max~ = 3424 (OH), 1650 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz): δ 3.54 (3H, s, OMe-1), 3.76 (3H, s, OMe-11), 4.11 (3H, s, OMe-2), 7.21 (1H, s, H-3), 7.22 (1H, d, *J* = 8.4 Hz, H-9), 7.77 (1H, d, *J* = 5.2 Hz, H-4), 8.31 (1H, d, *J* = 8.4 Hz, H-8), 8.86 (1H, d, *J* = 5.2 Hz, H-5); ESI-MS: *m*/*z* = 360 \[M + Na\]^+^.

*7-Oxonorisocorydine* (**7**): yellow needles; m.p. 250--252 °C (EtOAc); UV (MeOH): λ~max~ (log ε) = 212 (4.49), 273 (4.40), 362 (3.94), 403 (3.90) nm; IR (KBr): υ~max~ = 3385 (OH), 1653 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz): δ 3.53 (3H, s, OMe-1), 4.03 (3H, s, OMe-10), 4.08 (3H, s, OMe-2), 7.14 (1H, d, *J* = 8.4 Hz, H-9), 7.23 (1H, s, H-3), 7.77 (1H, d, *J* = 5.2 Hz, H-4), 8.28 (1H, d, *J* = 8.4 Hz, H-8), 8.86 (1H, d, *J* = 5.2 Hz, H-5); ESI-MS: *m*/*z* = 360 \[M + Na\]^+^.

*(--)-Deoxypodophyllotoxin* (**8**): colorless needles; m.p. 168--170 °C (MeOH); UV (MeOH): λ~max~ (log ε) = 212 (4.62), 291 (3.68) nm; IR (KBr): υ~max~ = 1765 (C=O), 1581, 1502, 1474 (aromatic ring C=C stretch), 1032, 941 (OCH~2~O) cm^−1^; ^1^H-NMR (CDCl~3~, 500 MHz): δ 2.73 (3H, m, H-7, H-8, and H-8′), 3.07 (1H, m, H-7), 3.75 (6H, s, OMe-3′, and OMe-5′), 3.80 (3H, s, OMe-4′), 3.92 (1H, m, H-9), 4.46 (1H, m, H-9), 4.60 (1H, d, *J* = 3.5 Hz, H-7′), 5.93, 5.95 (each 1H, each d, *J* = 1.5 Hz, OCH~2~O), 6.34 (2H, s, H-2′, and H-6′), 6.52 (1H, s, H-5), 6.67 (1H, s, H-2); ESI-MS: *m*/*z* = 421 \[M + Na\]^+^.

*Dehydropodophyllotoxin* (**9**): colorless needles; m.p. 264--266 °C (CH~2~Cl~2~-MeOH); UV (MeOH): λ~max~ (log ε) = 262 (4.57), 311 (3.95), 321 (3.97) nm; IR (KBr): υ~max~ = 3421 (OH), 1762 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 500 MHz): δ 3.83 (6H, s, OMe-3′, and OMe-5′), 3.95 (3H, s, OMe-4′), 5.37 (2H, br s, H-9), 5.68 (1H, br s, D~2~O exchangeable, OH-7), 6.10 (2H, s, OCH~2~O), 6.52 (2H, s, H-2′, and H-6′), 7.09 (1H, s, H-5), 7.49 (1H, s, H-2); ESI-MS: *m*/*z* = 433 \[M + Na\]^+^.

*(--)-Yatein* (**10**): yellowish solid (MeOH); UV (MeOH): λ~max~ (log ε) = 212 (4.35), 230 (sh, 3.93), 287 (3.47) nm; IR (KBr): υ~max~ = 1764 (C=O), 1591, 1502, 1488 (aromatic ring C=C stretch), 1037, 925 (OCH~2~O) cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz): δ 2.49 (1H, m, H-8), 2.53 (1H, m, H-7α), 2.58 (1H, m, H-8′), 2.62 (1H, dd, *J* = 13.2, 6.4 Hz, H-7β), 2.89 (1H, dd, *J* = 14.0, 6.2 Hz, H-7′α), 2.93 (1H, dd, *J* = 14.0, 5.2 Hz, H-7′β), 3.82 (6H, s, OMe-3′, and OMe-5′), 3.83 (3H, s, OMe-4′), 3.88 (1H, dd, *J* = 9.2, 7.6 Hz, H-9β), 4.18 (1H, dd, *J* = 9.2, 7.2 Hz, H-9α), 5.93, 5.94 (each 1H, each d, *J* = 1.2 Hz, OCH~2~O), 6.36 (2H, s, H-2′, and H-6′), 6.46 (1H, d, *J* = 1.6 Hz, H-2), 6.47 (1H, dd, *J* = 7.6, 1.6 Hz, H-6), 6.69 (1H, d, *J* = 7.6 Hz, H-5); ESI-MS: *m*/*z* = 423 \[M + Na\]^+^.

*N-trans-Feruloylmethoxytyramine* (**11**): white needles; m.p. 112--114 °C (CHCl~3~-MeOH); UV (MeOH): λ~max~ (log ε) = 221 (3.61), 290 (2.86), 319 (3.34) nm; IR (KBr): υ~max~ = 3362 (OH), 1652 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz): δ 2.82 (2H, t, *J* = 6.8 Hz, H-11), 3.62 (2H, q, *J* = 6.8 Hz, H-10), 3.88 (3H, s, OMe-14), 3.92 (3H, s, OMe-3), 5.52 (1H, br t, *J* = 6.8 Hz, D~2~O exchangeable, NH), 5.53 (1H, s, D~2~O exchangeable, OH), 5.79 (1H, s, D~2~O exchangeable, OH), 6.16 (1H, d, *J* = 15.6 Hz, H-8), 6.71 (1H, dd, *J* = 8.0, 1.6 Hz, H-17), 6.73 (1H, d, *J* = 1.6 Hz, H-13), 6.87 (1H, d, *J* = 8. Hz, H-16), 6.90 (1H, d, *J* = 8.4 Hz, H-5), 6.97 (1H, d, *J* = 1.6 Hz, H-2), 7.04 (1H, dd, *J* = 8.4, 1.6 Hz, H-5), 7.53 (1H, d, *J* = 15.6 Hz, H-7); ESI-MS: *m*/*z* = 366 \[M + Na\]^+^.

*Mixture of β-Sitostenone* (**12**) and stigmasta-4,22-dien-3-one (**13**): colorless needles; m.p. 88--90 °C (MeOH); \[α$\rbrack_{D}^{25}$ = +85.8° (*c* 0.18, CHCl~3~); UV (MeOH): λ~max~ (log ε) = 242 (4.21); IR (KBr): υ~max~ = 1685 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz) of **12**: δ 0.70 (3H, s, H-18), 0.81 (3H, d, *J* = 6.8 Hz, H-27), 0.83 (3H, d, *J* = 6.8 Hz, H-26), 0.86 (3H, t, *J* = 7.2 Hz, H-29), 0.92 (3H, d, *J* = 6.4 Hz, H-21), 1.18 (3H, s, H-19), 5.71 (1H, s, H-4); ^1^H-NMR (CDCl~3~, 400 MHz) of **13**: δ 0.72 (3H, s, H-18), 0.79 (3H, d, *J* = 6.8 Hz, H-27), 0.82 (3H, t, *J* = 7.2 Hz, H-29), 0.83 (3H, d, *J* = 6.8 Hz, H-26), 1.02 (3H, d, *J* = 6.8 Hz, H-21), 1.18 (3H, s, H-19), 5.02 (1H, dd, *J* = 15.2, 8.8 Hz, H-23), 5.14 (1H, dd, *J* = 15.2, 8.8 Hz, H-22), 5.71 (1H, s, H-4); ESI-MS of **12**: *m*/*z* = 435 \[M + Na\]^+^; ESI-MS of **13**: *m*/*z* = 433 \[M + Na\]^+^.

*Mixture of6β-Hydroxystigmast-4-en-3-one* (**14**) and 6β-hydroxystigmasta-4,22-dien-3-one (**15**): colorless needles; m.p. 208--209 °C (CH~2~Cl~2~-MeOH); \[α$\rbrack_{D}^{25}$ = + 29.7° (*c* 0.17, CHCl~3~); UV (MeOH): λ~max~ (log ε) = 235 (4.11) nm; IR (KBr): υ~max~ = 3412 (OH), 1679 (C=O) cm^−1^; ^1^H-NMR (CDCl~3~, 400 MHz) of **14**: δ 0.74 (3H, s, H-18), 0.81 (3H, d, *J* = 6.8 Hz, H-27), 0.84 (3H, d, *J* = 7.2 Hz, H-26), 0.87 (3H, t, *J* = 7.2 Hz, H-29), 0.92 (3H, d, *J* = 6.4 Hz, H-21), 1.38 (3H, s, H-19), 4.35 (1H, br s, H-6), 5.82 (1H, s, H-4); ^1^H-NMR (CDCl~3~, 500 MHz) of **15**: δ 0.76 (3H, s, H-18), 0.80 (3H, d, *J* = 6.8 Hz, H-27), 0.81 (3H, d, *J* = 6.8 Hz, H-26), 0.85 (3H, t, *J* = 7.2 Hz, H-29), 1.02 (3H, d, *J* = 6.8 Hz, H-21), 1.38 (3H, s, H-19), 4.35 (1H, br s, H-6), 5.03 (1H, dd, *J* = 15.2, 8.6 Hz, H-23), 5.15 (1H, dd, *J* = 15.2, 8.6 Hz, H-22), 5.82 (1H, s, H-4); ESI-MS of **14**: *m*/*z* = 451 \[M + Na\]^+^; ESI-MS of **15**: *m*/*z* = 449 \[M + Na\]^+^.

3.4. Biological Assay {#sec3dot4-molecules-23-02286}
---------------------

The effect of the isolates on the neutrophil proinflammatory response was assessed by detecting the inhibition of elastase release and O~2~^•−^ generation in fMLP/CB-activated neutrophils in a concentration-dependent manner.

### 3.4.1. Mensuration of Human Neutrophils {#sec3dot4dot1-molecules-23-02286}

Human neutrophils from the venous blood of adult, healthy volunteers (20--27 years old) were isolated by a standard pattern of dextran sedimentation before centrifugation in a Ficoll Hypaque gradient and hypotonic lysis of the erythrocytes \[[@B27-molecules-23-02286]\]. The purified neutrophils had \>98% viable cells, as detected by the trypan blue exclusion method \[[@B28-molecules-23-02286]\], were resuspended in a calcium (Ca^2+^)-free HBSS buffer at pH 7.4 and were kept at 4 °C prior to use.

### 3.4.2. Mensuration of Superoxide Anion (O~2~^•−^) Generation {#sec3dot4dot2-molecules-23-02286}

The assay for the measurement of O~2~^•−^ generation was based on the superoxide dismutase (SOD)-inhibitable reduction of ferricytochrome *c* \[[@B29-molecules-23-02286],[@B30-molecules-23-02286]\]. In short, after supplementation with 1 mM Ca^2+^ and 0.5 mg/mL ferricytochrome *c*, neutrophils (6 × 10^5^/mL) were equilibrated at 37 °C for 2 min and incubated with varied concentrations (10--0.01 μg/mL) of either DMSO (as a control) or tested compounds **1**--**15** (purity ≥ 98%) for 5 min. Cells were incubated with cytochalasin B (1 μg/mL) for 3 min before they were activated with 100 nM formyl-[l]{.smallcaps}-methionyl-[l]{.smallcaps}-leucyl-[l]{.smallcaps}-phenylalanine for 10 min. Changes in absorbance with the reduction of ferricytochrome *c* at 550 nm were constantly detected in a double-beam, six-cell positioner spectrophotometer with continuous stirring (Hitachi U-3010, Tokyo, Japan). Calculations were founded on differences in the reactions with and without SOD (100 U/mL) divided by the extinction coefficient for the reduction of ferricytochrome *c* (ε = 21.1/mM/10 mm).

### 3.4.3. Mensuration of Elastase Release {#sec3dot4dot3-molecules-23-02286}

The degranulation of azurophilic granules was measured by determining elastase release as reported previously \[[@B30-molecules-23-02286],[@B31-molecules-23-02286]\]. Assays were carried out by applying MeO-Suc-Ala-Ala-Pro-Val- *p*-nitroanilide as the elastase substrate. In brief, after supplementation with MeO-Suc-Ala-Ala-Pro-Val- *p*-nitroanilide (100 μM), neutrophils (6 × 10^5^/mL) were equilibrated at 37 °C for 2 min and incubated with tested compounds for 5 min. Cells were treated with fMLP (100 nM)/CB (0.5 μg/mL), and the changes in absorbance at 405 nm were detected constantly in order to measure elastase release. The results were displayed as the percent of elastase release in the fMLP/CB-activated, drug-free control system.

### 3.4.4. Statistical Analysis {#sec3dot4dot4-molecules-23-02286}

Results are represented as mean ± SEM, and comparisons were done by applying student's *t*-test. A probability of 0.05 or less was deemed significant. The software SigmaPlot was employed for the statistical analysis.

4. Conclusions {#sec4-molecules-23-02286}
==============

Fifteen compounds, including a new aporphine, 3-hydroxyhernandonine (**1**), and a new lignin, 4′-*O*-demethyl-7-*O*-methyldehydropodophyllotoxin (**2**), were isolated from the resinous wood of the root wood of *H. nymphaeifolia*. The structures of these isolates were elucidated according to spectroscopic data. Granule proteases (e.g., cathepsin G, elastase) and reactive oxygen species (ROS) \[e.g., hydrogen peroxide, superoxide anion (O~2~^•−^)\] generated by human neutrophils gave rise to the pathogenesis of inflammatory diseases. The effects of the isolated compounds on proinflammatory responses were assessed by inhibiting fMLP/CB-induced elastase release and O~2~^•−^ generation by neutrophils. The results of anti-inflammatory assays reveal that compounds **1**--**7** and **11** can obviously inhibit fMLP-induced elastase release and/or O~2~^•−^ generation. Oxohernangerine (**5**) and 3-hydroxyhernandonine (**1**) were the most effective among the isolated compounds, with IC~50~ values of 2.65 ± 0.97 and 3.93 ± 0.48 μg/mL, respectively, against fMLP-induced O~2~^•--^ generation and elastase release. Our research indicates *H. nymphaeifolia* and its isolated compounds (especially **1**--**7** and **11**) are worth further study and may be expectantly developed as candidates for the prevention or treatment of diverse inflammatory diseases.
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###### 

The chemical structures of compounds **1**--**15** isolated from *H. nymphaeifolia*.
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###### 

Inhibitory effects of compounds **1**--**15** from the root wood of *H. nymphaeifolia* on superoxide radical anion generation and elastase release by human neutrophils in response to fMet-Leu-Phe/cytochalasin B ^a^.

  ----------------------------------------------------------------------------------------------------------------------------------------------------
  Compounds                                                                                            Superoxide anion        Elastase
  ---------------------------------------------------------------------------------------------------- ----------------------- -----------------------
  3-Hydroxyhernandonine (**1**)                                                                        4.09 ± 0.44 \*\*\*      3.93 ± 0.48 \*\*\*

  4′-*O*-Demethyl-7-*O*-\                                                                              5.72 ± 0.42 \*\*\*      5.40 ± 0.40 \*\*\*
  methyldehydro-podophyllotoxin (**2**)                                                                                        

  2-*O*-Methyl-7-oxolaetine (**3**)                                                                    7.37 ± 0.46 \*\*\*      6.82 ± 0.09 \*\*\*

  Hernandonine (**4**)                                                                                 4.41 ± 0.76 \*\*\*      (45.76 ± 6.92) \*\*\*

  Oxohernangerine (**5**)                                                                              2.65 ± 0.97 \*\*\*      4.82 ± 0.39 \*\*\*

  Oxohernagine (**6**)                                                                                 2.86 ± 0.85 \*\*\*      4.87 ± 0.27 \*\*\*

  7-Oxonorisocorydine (**7**)                                                                          6.62 ± 0.28 \*\*\*      6.58 ± 0.08 \*\*\*

  (--)-Deoxypodophyllotoxin (**8**)                                                                    (38.95 ± 4.83) \*\*     (33.76 ± 3.82)

  Dehydropodophyllotoxin (**9**)                                                                       (43.91 ± 3.86) \*\*\*   9.53 ± 0.84 \*\*\*

  (--)-Yatein (**10**)                                                                                 (42.36 ± 3.41) \*       (36.74 ± 3.05) \*\*

  *N*-*trans*-Feruloylmethoxytyramine (**11**)                                                         6.26 ± 0.65 \*\*\*      7.03 ± 0.21 \*\*\*

  Mixture of β-sitostenone (**12**) and stigmasta-4,22-dien-3-one (**13**)                             (24.71 ± 2.67)          (29.15 ± 2.89)

  Mixture of 6β-hydroxystigmast-4-en-3-one (**14**) and 6β-hydroxystigmasta-4,22-dien-3-one (**15**)   (16.74 ± 2.66) \*\*     7.91 ± 1.20 \*\*

  Diphenyleneiodonium ^d^                                                                              0.55 ± 0.22 \*\*\*      --

  Phenylmethylsulfonyl fluoride ^d^                                                                    --                      34.5 ± 5.3 \*\*\*
  ----------------------------------------------------------------------------------------------------------------------------------------------------

^a^ Results are displayed as averages ± SEM (*n* = 4). ^b^ Concentration necessary for 50% inhibition (IC~50~). If IC~50~ value of tested compound was \<10 μg/mL, it was presented as IC~50~ \[μg/mL\]. ^c^ Percentage of inhibition (Inh %) at 10 μg/mL. If IC~50~ value of tested compound was ≥10 μg/mL, it was displayed as (Inh %) at 10 μg/mL. ^d^ Diphenyleneiodonium and phenylmethylsulfonyl were employed as positive controls for superoxide anion (O~2~^•--^) production and elastase release, respectively. \* *p* \< 0.05 compared with the control. \*\* *p* \< 0.01 compared with the control. \*\*\* *p* \< 0.001 compared with the control.

[^1]: Authors have contributed equally in this manuscript.
